Latest News about VRTX
Recent news which mentions VRTX
Key Takeaways From Vertex Pharmaceuticals Analyst Ratings
January 31, 2024
Tickers
VRTX
From Benzinga
Why Vertex Pharmaceuticals Stock Topped the Market Today
January 30, 2024
Tickers
VRTX
From Motley Fool
Why Is Vertex Pharmaceuticals Stock Sliding Today?
January 30, 2024
From Benzinga
Is CRISPR Therapeutics a Buy in the New Bull Market?
January 30, 2024
From Motley Fool
AI, Biotech, Energy Sectors Expect M&A Revival For 2024
January 29, 2024
From Benzinga
3 Magnificent Stocks to Buy and Hold Forever
January 27, 2024
From Motley Fool
Could Sarepta Therapeutics Become the Next Vertex Pharmaceuticals?
January 25, 2024
From Motley Fool
Biotech Stocks Are on Fire: Here Are the Top 3 Picks for January
January 25, 2024
From InvestorPlace
Slow Market Penetration For Biogen's Another Alzheimer's Drug: UBS Highlights Risks, Forecasts
January 24, 2024
From Benzinga
Where Will CRISPR Therapeutics Be in 5 Years?
January 24, 2024
From Motley Fool
From Benzinga
2 Super Stocks You'll Wish 5 Years From Now That You'd Bought Today
January 24, 2024
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
January 23, 2024
From Benzinga
A Look Into Vertex Pharmaceuticals Inc's Price Over Earnings
January 23, 2024
From Benzinga
1 Setback and 1 Opportunity for CRISPR Therapeutics Stock
January 23, 2024
From Motley Fool
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
January 22, 2024
From Benzinga
Here's How Much $1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today
January 22, 2024
From Benzinga
If You Invested $10,000 in Vertex Pharmaceuticals in 2018, This Is How Much You Would Have Today
January 22, 2024
From Motley Fool
2 Smart Growth Stocks to Buy Hand Over Fist in 2024
January 21, 2024
From Motley Fool
3 Unstoppable Growth Stocks That Can Make You Richer in 2024
January 20, 2024
From Motley Fool
These 2 Phenomenal Growth Stocks Can Make You Richer in 2024
January 20, 2024
From Motley Fool
3 High-Flying Stocks That Could Soar Even More in 2024
January 20, 2024
From Motley Fool
Gene Therapy For Beta-Thalassemia: CRISPR Therapeutics/Vertex's Casgevy Secures FDA Nod Ahead of Schedule
January 17, 2024
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 16, 2024
From Benzinga
Here's Why CRISPR Therapeutics Stock Rose 54% Last Year
January 15, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.